SCHEMBL13759405

SCHEMBL13759405

O=Cc1cc(C(F)(F)F)cc2nc[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.45
MAPT P10636 2/20 0.36
S1PR1 P21453 1/20 0.36
P2RY14 Q15391 1/20 0.33
POLB P06746 2/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
QPCT Q16769 3/20 0.31
TEK Q02763 1/20 0.31
ALDH1A1 P00352 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CDK1 P06493 1/20 0.30
BRAF P15056 1/20 0.30
KDM5A P29375 1/20 0.30
KDM4C Q9H3R0 1/20 0.30
KDM5B Q9UGL1 1/20 0.30
CTSS P25774 1/20 0.30
CTSK P43235 1/20 0.30
CDC7 O00311 1/20 0.30
DBF4 Q9UBU7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29285163 0.78 PARP1 (0.41) PARP1MAPTPOLBQPCTALDH1A1
SCHEMBL16129491 0.76 PARP1 (0.46) PARP1MAPTS1PR1QPCTCDK1
SCHEMBL2298425 0.75 PARP1 (0.45) PARP1MAPTS1PR1P2RY14TEK
SCHEMBL22361949 0.75 PARP1 (0.45) PARP1MAPTS1PR1POLBALDH1A1
SCHEMBL11565241 0.75 PARP1 (0.45) PARP1MAPTS1PR1ALDH1A1BRAF
SCHEMBL2424011 0.74 CTSS (0.39) PARP1MAPTS1PR1P2RY14ALOX5AP
SCHEMBL2426912 0.74 ALDH1A1 (0.31) POLBALDH1A1L3MBTL1
SCHEMBL15093877 0.73 PARP1 (0.44) PARP1MAPTS1PR1P2RY14TEK
Hydrochloric Acid SCHEMBL20562251 0.72 PARP1 (0.43) PARP1MAPTS1PR1P2RY14TEK
SCHEMBL11869664 0.72 ALDH1A1 (0.50) PARP1MAPTPOLBALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557120-B2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity MERCK & CO., INC. (US) 2009-07-07 US disclosed
US-7557120-B2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity MERCK & CO., INC. (US) 2009-07-07 US disclosed
US-20070004714-A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity MERCK & CO., INC. (US) 2007-01-04 US disclosed
US-20070004714-A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity MERCK & CO., INC. (US) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004714-A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity CCR2, CCR1, CCR8 PARP1 3206/4885MAPT 4550/4885S1PR1 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.